Open Access Research article

Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial

Dona L Fleishaker*, Juan A Garcia Meijide, Andriy Petrov, Michael David Kohen, Xin Wang, Sujatha Menon, Thomas C Stock, Charles A Mebus, James M Goodrich, Howard B Mayer and Bernhardt G Zeiher

Arthritis Research & Therapy 2012, 14:R11  doi:10.1186/ar3685


See related editorial by Takeuchi and Kameda, http://arthritis-research.com/content/14/2/114

Accesses  

  • Last 30 days: 63 accesses
  • Last 365 days: 1041 accesses
  • All time: 2916 accesses

Cited by